Kopran Limited

NSE KOPRAN.NS

Kopran Limited Gross Profit Margin for the year ending March 31, 2024: 33.54%

Kopran Limited Gross Profit Margin is 33.54% for the year ending March 31, 2024, a -3.96% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Kopran Limited Gross Profit Margin for the year ending March 31, 2023 was 34.92%, a -12.90% change year over year.
Kopran Limited Gross Profit Margin for the year ending March 31, 2022 was 40.10%, a 15.48% change year over year.
Kopran Limited Gross Profit Margin for the year ending March 31, 2021 was 34.72%, a -6.54% change year over year.
Kopran Limited Gross Profit Margin for the year ending March 31, 2020 was 37.15%, a 0.89% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NSE: KOPRAN.NS

Kopran Limited

CEO	Mr. Surendra Shrikrishna Somani B.Com.
IPO Date	July 1, 2002
Location	India
Headquarters	Parijat House
Employees	842
Sector	Health Care
Industries Pharmaceuticals

Description

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.

Key trends

Past 5 years